Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Identification of an Alternative GATA-3 Promoter Directing Tissue-Specific Gene Expression in Mouse and Human

Hélène Asnagli, Maryam Afkarian and Kenneth M. Murphy
J Immunol May 1, 2002, 168 (9) 4268-4271; DOI: https://doi.org/10.4049/jimmunol.168.9.4268
Hélène Asnagli
Department of Pathology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Afkarian
Department of Pathology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth M. Murphy
Department of Pathology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  •            FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Distinct modes of GATA-3 gene expression exhibited by naive and differentiated T cells. A, For naive T cells (lanes 1–3), CD4+Mel-14high T cells were sorted from DO11.10 TCR-transgenic mice and activated as described (9 ) with the additions (+) of cytokines or Abs. Anti-IFN-γ (H22), 5 μg/ml, was included in all conditions. Anti-IL-12 (1:10) was added to all conditions except where IL-12 cytokine was added (lane 3). For effector analysis (lanes 4–8), T cells were primed either in Th0 conditions (anti-IL-12, 1/10 (23 ); anti-IL-4, 1/10 (22 ), and anti-IFN-γ (H22), 5 μg/ml (24 ), or in Th1 or Th2 conditions (9 ). For effector T cells, cells were harvested on day 7 and restimulated with plate-bound anti-CD3 Ab (TCR) (1/1000) in the presence (+) of the indicated cytokines or Abs. After 48 h, cells were harvested and analyzed by Northern blot. B, Th1 or Th2 effector cells as described in A were restimulated on day 7 after primary stimulation and restimulated with (+) or without (−) plate-bound anti-CD3 Ab (TCR), with (+) or without (−) addition of IL-4 or anti-IL-4 Ab.

  •            FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Conservation of murine and human GATA-3 exon 1a and flanking sequences. The sequence of the exon 1a derived above (RACE) was aligned with homologous sequences identified from the murine and human genome databases from the Celera Discovery System. Sequence analysis for potential cis-regulatory elements was performed using Transfac resources (27 ).

  •            FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Differential usage of GATA-3 exons 1a and 1b in mouse tissue and cell lines. A, Primers used for RT-PCT analysis. Primers a and c are specific for the 1a and 1b exons. Primer b is antisense to exon 2 and is used in both reactions. Primers 1a-AS and 1b-AS are antisense to exons 1a and 1b, respectively, and are used for hybridization to PCR products. B, RT-PCR analysis of exons 1a and 1b. RNA is from the indicated cells. Controls are shown either with no reverse transcriptase (lane 7), no RNA (lane 9) or positive control with plasmids (lane 8). C, RNA from T cells under Th2 differentiation was extracted at the indicated time course point, and RT-PCR was performed using the primers shown in A. D, RNA was harvested from naive cells (lanes 1 and 2) after 48 h stimulation with coated anti-CD3/CD28 in presence of Abs against IL-4 and IFN-γ (lane 1) or in presence of IL-4 with Ab against IFN-γ (lane 2). RNA from day 7 Th2 (lanes 3–5) or Th1 (lane 6) cells was harvested after 48 h of restimulation with splenic APCs and anti-IFN-γ, anti-IL-12 and IL-4 or anti-IL-4 Abs as indicated. As controls, RNA from thymus or brain in the presence or absence of reverse transcriptase (RT) reverse transcription as indicated (lanes 7–10), no RNA (lane 11), or plasmid-positive control (lane 12).

PreviousNext
Back to top

In this issue

The Journal of Immunology: 168 (9)
The Journal of Immunology
Vol. 168, Issue 9
1 May 2002
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Identification of an Alternative GATA-3 Promoter Directing Tissue-Specific Gene Expression in Mouse and Human
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Identification of an Alternative GATA-3 Promoter Directing Tissue-Specific Gene Expression in Mouse and Human
Hélène Asnagli, Maryam Afkarian, Kenneth M. Murphy
The Journal of Immunology May 1, 2002, 168 (9) 4268-4271; DOI: 10.4049/jimmunol.168.9.4268

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Identification of an Alternative GATA-3 Promoter Directing Tissue-Specific Gene Expression in Mouse and Human
Hélène Asnagli, Maryam Afkarian, Kenneth M. Murphy
The Journal of Immunology May 1, 2002, 168 (9) 4268-4271; DOI: 10.4049/jimmunol.168.9.4268
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients
  • Cutting Edge: Promoting T Cell Factor 1+ T Cell Self-Renewal to Improve Programmed Cell Death Protein 1 Blockade
  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606